|
- News - Visus Therapeutics™
Visus Therapeutics™ is a clinical-stage company developing innovative medicines to improve vision for people around the world
- Home - Visus Therapeutics™
Visus Therapeutics™ is a clinical-stage company developing innovative medicines to improve vision for people around the world
- Visus Initiates Phase 3 Trial of Brimochol PF to Treat Presbyopia
The first of two pivotal phase 3 trials that will assess the safety and efficacy of Brimochol PF for the treatment of presbyopia is underway, according to a press release from Visus Therapeutics
- Careers - Visus Therapeutics™
While our team comes from diverse backgrounds and experiences, one trait we all have in common is what we call the Visus “spark ” It’s a spirit of collaboration that celebrates different perspectives and ignites creativity and innovation in everything we do
- Brimochol PF achieves endpoints in phase 3 presbyopia trial
Visus Therapeutics, Inc 2 Nickerson St Ste 101 Seattle, WA 98109 Careers Contact Us Terms of Use Privacy Policy © VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc
- New options are on the horizon for presbyopia-correcting drops
Visus Therapeutics, Inc 2 Nickerson St Ste 101 Seattle, WA 98109 Careers Contact Us Terms of Use Privacy Policy © VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc
- Answering the Call of Presbyopic Patients - visustx. com
Visus Therapeutics, Inc 2 Nickerson St Ste 101 Seattle, WA 98109 Careers Contact Us Terms of Use Privacy Policy © VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc
- The Latest Roundup of Key Presbyopia–Correcting Drops
Visus Therapeutics, Inc 2 Nickerson St Ste 101 Seattle, WA 98109 Careers Contact Us Terms of Use Privacy Policy © VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc
|
|
|